Importance of the Epidemic Curve for Cross-country Comparison of COVID-19 Mortality: A Brief Analysis on Interpreting the Pandemic Numbers

S. Rizoli, G. Fraga, Bartolomeu Nascimento, Lorena T de Melo Rolim
{"title":"Importance of the Epidemic Curve for Cross-country Comparison of COVID-19 Mortality: A Brief Analysis on Interpreting the Pandemic Numbers","authors":"S. Rizoli, G. Fraga, Bartolomeu Nascimento, Lorena T de Melo Rolim","doi":"10.5005/jp-journals-10030-1276","DOIUrl":null,"url":null,"abstract":"Our planet is experiencing an unprecedented public health crisis. The ongoing COVID-19 pandemic is ubiquitously making headlines daily. Currently, 216 countries, areas, or territories have documented COVID-19 cases. Many are publicizing numbers of deaths per population by country as a measure of a “country’s performance” in handling this global crisis. Indeed, death ranks are being created to ascertain a “nation’s failure or success.” Due to the pandemic, the World Health Organization (WHO) has made available daily data on COVID-19 cases and mortality.1 This is extremely valuable to inform countries on the spread of the disease and its lethality. This information can guide pandemic preparedness plans across the globe. However, caution should be exercised when using such data for unadjusted cross-country comparisons, particularly on disease lethality. Increasing death rates are naturally observed as an epidemic takes its course. The epidemic curve is a visual display of outbreak cases.2 It starts with the first confirmed case in a population. Then, it develops as an expression mainly of the incubation period, mode of transmission, and transmissibility. The number of cases and associated deaths of a disease grow exponentially on its epidemic curve. The goal of this brief analysis is to demonstrate that mortality rates are modifiable when considering the pandemic phase of each country. In order to adjust for the epidemic curve of COVID19 in countries with higher numbers of deaths according to the WHO available data, we calculated the time elapsed between the first reported case and May 16, 2020. All countries included had a minimum of 80 days into their epidemic curve. The Netherlands had the shortest epidemic curve with 80 days. Then, this was used as the reference epidemic curve for cross-country comparison. We also reported mortality rates per 1,000,000 inhabitants. On the WHO online dashboard, the absolute number of new deaths by country is reported daily as well as the number of cumulative deaths over the pandemic period. We included the top 10 countries with the highest cumulative numbers of deaths listed by the WHO on May 16, 2020. With 118 pandemic days, the United States had the highest absolute number of deaths for the period. Among the top 10 countries, the Netherlands reported the lowest absolute number of deaths (Table 1). However, considering the country population, the U.S. mortality dropped to 7° place and Brazil had the lowest mortality rate on the rank of all countries analyzed (Table 1). When accounting for the epidemic curve, we observed additional changes on the rank of countries by mortality rates (Table 2). Interestingly, the United States had the lowest mortality rate of all countries included. Belgium appeared as the country with the highest death rate among the top 10 countries. In this new scenario, the United States had a mortality rate of approximately 14 times lower than the one seen for Belgium. Brazil, the only South America country, registered one of the lowest mortality rates, only being superior to the ones documented in the United States and Germany. 1Diretoria, Hospital Getulio Vargas, Recife, Pernambuco, Brazil 2Medicina, Faculdade Pernambucana de Saude, Recife, Pernambuco, Brazil 3Department of Cirurgia, Unicamp, Campinas, São Paulo, Brazil 4Hamad General Hospital, Qatar Corresponding Author: Bartolomeu A Nascimento Jr, Diretoria, Hospital Getulio Vargas, Recife, Pernambuco, Brazil, Phone: +558131845606, e-mail: Barto.NascimentoJr@outlook.com How to cite this article: Nascimento Jr BA, de Melo Rolim LT, Fraga GP, et al. The Importance of the Epidemic Curve for Cross-Country Comparison of COVID-19 Mortality: A Brief Analysis on Interpreting the Pandemic Numbers. Panam J Trauma Crit Care Emerg Surg 2020;XX(X):1–2. Source of support: Nil Conflict of interest: None","PeriodicalId":74395,"journal":{"name":"Panamerican journal of trauma, critical care & emergency surgery","volume":"130 1","pages":"120-121"},"PeriodicalIF":0.0000,"publicationDate":"2020-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Panamerican journal of trauma, critical care & emergency surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5005/jp-journals-10030-1276","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Our planet is experiencing an unprecedented public health crisis. The ongoing COVID-19 pandemic is ubiquitously making headlines daily. Currently, 216 countries, areas, or territories have documented COVID-19 cases. Many are publicizing numbers of deaths per population by country as a measure of a “country’s performance” in handling this global crisis. Indeed, death ranks are being created to ascertain a “nation’s failure or success.” Due to the pandemic, the World Health Organization (WHO) has made available daily data on COVID-19 cases and mortality.1 This is extremely valuable to inform countries on the spread of the disease and its lethality. This information can guide pandemic preparedness plans across the globe. However, caution should be exercised when using such data for unadjusted cross-country comparisons, particularly on disease lethality. Increasing death rates are naturally observed as an epidemic takes its course. The epidemic curve is a visual display of outbreak cases.2 It starts with the first confirmed case in a population. Then, it develops as an expression mainly of the incubation period, mode of transmission, and transmissibility. The number of cases and associated deaths of a disease grow exponentially on its epidemic curve. The goal of this brief analysis is to demonstrate that mortality rates are modifiable when considering the pandemic phase of each country. In order to adjust for the epidemic curve of COVID19 in countries with higher numbers of deaths according to the WHO available data, we calculated the time elapsed between the first reported case and May 16, 2020. All countries included had a minimum of 80 days into their epidemic curve. The Netherlands had the shortest epidemic curve with 80 days. Then, this was used as the reference epidemic curve for cross-country comparison. We also reported mortality rates per 1,000,000 inhabitants. On the WHO online dashboard, the absolute number of new deaths by country is reported daily as well as the number of cumulative deaths over the pandemic period. We included the top 10 countries with the highest cumulative numbers of deaths listed by the WHO on May 16, 2020. With 118 pandemic days, the United States had the highest absolute number of deaths for the period. Among the top 10 countries, the Netherlands reported the lowest absolute number of deaths (Table 1). However, considering the country population, the U.S. mortality dropped to 7° place and Brazil had the lowest mortality rate on the rank of all countries analyzed (Table 1). When accounting for the epidemic curve, we observed additional changes on the rank of countries by mortality rates (Table 2). Interestingly, the United States had the lowest mortality rate of all countries included. Belgium appeared as the country with the highest death rate among the top 10 countries. In this new scenario, the United States had a mortality rate of approximately 14 times lower than the one seen for Belgium. Brazil, the only South America country, registered one of the lowest mortality rates, only being superior to the ones documented in the United States and Germany. 1Diretoria, Hospital Getulio Vargas, Recife, Pernambuco, Brazil 2Medicina, Faculdade Pernambucana de Saude, Recife, Pernambuco, Brazil 3Department of Cirurgia, Unicamp, Campinas, São Paulo, Brazil 4Hamad General Hospital, Qatar Corresponding Author: Bartolomeu A Nascimento Jr, Diretoria, Hospital Getulio Vargas, Recife, Pernambuco, Brazil, Phone: +558131845606, e-mail: Barto.NascimentoJr@outlook.com How to cite this article: Nascimento Jr BA, de Melo Rolim LT, Fraga GP, et al. The Importance of the Epidemic Curve for Cross-Country Comparison of COVID-19 Mortality: A Brief Analysis on Interpreting the Pandemic Numbers. Panam J Trauma Crit Care Emerg Surg 2020;XX(X):1–2. Source of support: Nil Conflict of interest: None
流行曲线对COVID-19死亡率跨国比较的重要性——对大流行数字的简要解读
我们的星球正在经历一场前所未有的公共卫生危机。持续的COVID-19大流行每天都在成为头条新闻。目前,有216个国家、地区或领土记录了COVID-19病例。许多国家正在公布按国家分列的人均死亡人数,作为衡量一个国家在处理这一全球危机方面“表现”的标准。实际上,设立死亡等级是为了确定一个“国家的成败”。由于大流行,世界卫生组织(世卫组织)每天都提供COVID-19病例和死亡率的数据这对于向各国通报该疾病的传播及其致命性非常有价值。这些信息可以指导全球的大流行防范计划。然而,在使用此类数据进行未经调整的跨国比较时,特别是在疾病致死率方面,应谨慎进行。随着流行病的发展,死亡率自然会上升。流行曲线是爆发病例的直观显示它从人群中的第一例确诊病例开始。然后,它主要表现为潜伏期、传播方式和传播能力。一种疾病的病例数和相关死亡人数在其流行曲线上呈指数增长。这一简要分析的目的是证明,在考虑到每个国家的大流行阶段时,死亡率是可以改变的。为了根据世卫组织现有数据调整covid - 19在死亡人数较高的国家的流行曲线,我们计算了从第一例报告病例到2020年5月16日之间的时间。所列所有国家的流行曲线至少有80天。荷兰的流行曲线最短,为80天。并以此为参考流行曲线进行跨国比较。我们还报告了每100万居民的死亡率。在世卫组织在线仪表板上,每天报告各国新增死亡人数的绝对数字以及大流行期间的累计死亡人数。我们纳入了世界卫生组织在2020年5月16日列出的累计死亡人数最多的前10个国家。在118天的大流行期间,美国的绝对死亡人数最多。在排名前10位的国家中,荷兰报告的绝对死亡人数最低(表1)。然而,考虑到国家人口,美国的死亡率下降到7位,巴西的死亡率在所有分析国家的排名中最低(表1)。当考虑到流行曲线时,我们观察到按死亡率排名的国家的其他变化(表2)。有趣的是,美国的死亡率在所有纳入的国家中最低。在前10个国家中,比利时的死亡率最高。在这种新的情况下,美国的死亡率比比利时低大约14倍。巴西是南美洲唯一一个死亡率最低的国家之一,仅高于美国和德国记录的死亡率。1巴西累西腓Getulio Vargas医院,巴西伯南布哥省累西腓,medicina,伯南布哥省伯累西腓,沙特伯南布迦医学院,巴西圣保罗,坎皮纳斯,Unicamp, Cirurgia科,巴西,卡塔尔,哈马德总医院Bartolomeu A NascimentoJr, gertulio Vargas医院,累西腓,巴西,电话:+558131845606,电子邮件:Barto.NascimentoJr@outlook.com本文引用方式:NascimentoJr BA, de Melo Rolim LT, Fraga GP,等。流行曲线对COVID-19死亡率跨国比较的重要性——对大流行数字的简要解读中华创伤急救外科杂志2020;XX(X): 1-2。支持来源:无利益冲突:无
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信